JPM vs MRK: Which Is the Better Buy?
Side-by-side comparison of JPMorgan Chase & Co. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
JPMorgan Chase & Co. · Financial Services
$309.87
-6.4% upside to fair value
High Conviction
Grade A-
VS
Merck & Co., Inc. · Healthcare
$121.42
-2.9% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
MRK has more upside to fair value
(-2.9%).
MRK trades at a lower forward P/E
(14.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JPM |
MRK |
| Current Price |
$309.87 |
$121.42 |
| Fair Value Estimate |
$290.00 |
$118.00 |
| Upside to Fair Value |
-6.4%
|
-2.9%
|
| Market Cap |
$835.7B |
$300.2B |
| Forward P/E |
14.3x
|
14.0x
|
| EV / EBITDA |
17.6x
|
11.8x
|
| Price / Sales |
3.0x
|
4.1x
|
| Price / FCF |
—
|
21.4x
|
| Revenue Growth YoY |
+3.3%
|
+1.3%
|
| Gross Margin |
59.99%
|
81.5%
|
| Operating Margin |
25.9%
|
41.2%
|
| Return on Equity |
15.95%
|
34.7%
|
| Dividend Yield |
1.9% |
3.1% |
| FCF Yield |
—
|
4.7%
|
| Analyst Consensus |
Overweight
|
Buy
|
Investment Thesis
JPMorgan Chase is the largest U.S. bank by assets ($4.4T) and the most diversified financial services franchise globally, operating across consumer banking, investment banking, commercial banking, and asset management. Under Jamie Dimon's two-decade leadership, the firm has consistently gained market share, delivered sector-leading ROE of 16%, and invested aggressively in technology ($17B+ annual…
Merck is a top-5 global pharmaceutical company generating $65B in annual revenue with 81.5% gross margins and 28% net margins. Keytruda, the world's best-selling drug at $31.7B (49% of pharma revenue), faces patent expiry in 2028. Merck is aggressively building replacements through M&A and pipeline launches: Winrevair ($1.4B year one), Capvaxive ($759M), and the $6.7B Terns acquisition for TERN-7…
Accumulation Zones
| Metric |
JPM |
MRK |
| Zone Low |
$220.00 |
$88.00 |
| Zone High |
$250.00 |
$100.00 |
| In Buy Zone? |
No
|
No
|